Original Contribution |
Presented previously in abstract form (Biophys J. 1998;74:A325).
From the Departments of Internal Medicine (H.F.C.) and Physiology (H.F.C., C.M.B.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Va, and Division of Cardiology (B.S.S.), Case Western Reserve University, and University Hospitals of Cleveland, Cleveland, Ohio.
Correspondence to Henry F. Clemo, MD, PhD, Department of Physiology, Medical College of Virginia, PO Box 980551, Richmond, VA 23298-0551. E-mail hclemo{at}hsc.vcu.edu
| Abstract |
|---|
|
|
|---|
Key Words: arrhythmia cardiomyopathy cardiac edema cell size ion channel gating
| Introduction |
|---|
|
|
|---|
The significance of ICl,swell for cardiac function under physiological and pathophysiological conditions remains uncertain. On the basis of the magnitude and voltage dependence of the current, activation of ICl,swell is thought to modulate cardiac electrical activity.15 16 In addition, we reported17 that 9-anthracene carboxylic acid (9AC), a blocker of ICl,swell,1 18 increases the volume of intact ventricular myocytes after osmotic swelling when ICl,swell is expected to be activated, but 9AC has no effect on cell volume under isosmotic conditions when the channels underlying ICl,swell are thought to be closed.
Another situation in which ICl,swell may be important is congestive heart failure (CHF). The hemodynamic perturbations responsible for the development of CHF and cellular hypertrophy place myocytes under mechanical stress and lead to complex cellular remodeling19 and activation of multiple intracellular signaling systems.20 Using the perforated-patch voltage clamp method, we recently found that ICir,swell, an inwardly rectifying, Gd3+-sensitive cation current normally detected only after osmotic cell swelling,21 became persistently activated under isosmotic conditions in ventricular myocytes isolated from animals with CHF induced by tachycardia.22 Moreover, block of ICir,swell resulted in significant volume changes in normal rabbit,21 as well as in normal and CHF dog22 myocytes.
In light of the modulation of swelling-activated cation channels by CHF, the present study was designed to determine whether ICl,swell also is transformed in a canine model of CHF produced by several weeks of rapid ventricular pacing. This model has been extensively characterized in both dogs and pigs.23 Chronic tachycardia produces biventricular dilation with eccentric cellular hypertrophy, decreases contractility, downregulates the response to catecholamines, atrial natriuretic peptide, renin, and endothelin-I, and decreases the density of the myocardial collagen network. These characteristics are shared with dilated cardiomyopathy in humans,24 25 26 27 and the model is useful for considering the role of ICl,swell in CHF.
Concurrent perforated-patch voltage clamp and cell-volume determinations revealed that ICl,swell was persistently activated in isosmotic media in ventricular myocytes isolated from dogs with CHF. Osmotic swelling did not significantly increase ICl,swell, and osmotic shrinkage inhibited the current. In contrast, ICl,swell was found in normal canine myocytes only after osmotic swelling. In addition, 9AC induced cell swelling that was proportional to the magnitude ICl,swell blocked in both CHF and normal myocytes. These data are consistent with the idea that elongated hypertrophic myocytes from dogs in CHF behave as if they are swollen. Anion fluxes via ICl,swell may contribute to the sequelae of CHF and may represent a novel target for therapy.
| Materials and Methods |
|---|
|
|
|---|
Cell Isolation
Using a median thoracotomy approach, portions of the left and
right ventricle were taken from anesthetized dogs (normal n=4,
CHF n=6). After washing in nominally Ca2+-free
Tyrode solution equilibrated with 100% O2, the
right- and left-ventricular samples were then divided into
1-mm2 pieces with a scalpel and were dispersed
in an albumin-containing collagenase-pronase
solution described previously.22 28 After filtration to
remove incompletely digested material, the isolated cells were washed
twice and then stored in a modified Kraft-Brühe solution
containing (in mmol/L) 132 KOH, 120 glutamic acid, 2.5 KCl, 10
KH2PO4, 1.8
MgSO4, 0.5 K2EGTA, 11
glucose, 10 taurine, and 10 HEPES (pH 7.2; 295 mOsmol/L). Typical
yields were
50% Ca2+-tolerant, rod-shaped
cells. Myocytes were used within 6 hours of harvesting, and only
quiescent cells with regular striations and no evidence of membrane
blebbing were selected for study.
Experimental Solutions
Cells were placed in a glass-bottomed chamber (
0.3 mL) and
were superfused with bathing solution (
22°C) at 3 mL/min; solution
changes were complete within 10 s. The standard bathing solution
contained (in mmol/L) 65 NaCl, 5 KCl, 2.5
CaSO4, 0.5 MgSO4, 5 HEPES,
10 glucose, and 17 to 283 mannitol (pH 7.4). Solutions were designed to
allow adjustment of osmolarity with mannitol at a constant ionic
strength. The role of physiological cations and
anions was evaluated by replacing Na+ and
K+ in the bathing media with equimolar amounts of
N-methyl-D-glucamine (NMDG) in
some experiments and by replacing Cl in the
bathing media with equimolar amounts of methanesulfonate in others.
Isosmotic (IT; T, relative osmolarity) solution was set
as 296 mOsmol/L. The osmolarity of hyposmotic solutions (0.6T to 0.9T)
ranged from 178 to 266 mOsmol/L and was 444 mOsmol/L in hyperosmotic
solutions (1.5T). A freezing-point depression osmometer (Osmette S;
Precision Systems) was used to routinely verify solution
composition.
Voltage Clamp Technique
Patch electrodes with a tip diameter of 3 to 4 µm and a
resistance of 0.5 to 1 M
were made from borosilicate capillary
tubing (7740 glass with filament; 1.5 mm OD, 1.12 mm ID).
Pipettes usually were filled with solution containing (in mmol/L)
120 potassium aspartate; 10 KCl, 10 NaCl, 3
MgSO4, and 10 HEPES (pH 7.1). For experiments in
Na+- and K+-free bathing
media, Na+ and K+ salts in
the pipette solution were replaced with Cs+
salts, and for experiments in Cl-free bathing
media, Cl in the pipette solution was reduced
to
5 mmol/L by replacing NaCl and KCl with the corresponding
aspartate salts.
The perforated-patch method was used for all studies to avoid
unpredictable cell swelling and changes in membrane currents that often
slowly occur with the ruptured patch technique.2 21
Amphotericin-B (Sigma Chemical Co) was freshly dissolved in DMSO
(Sigma) and then diluted in electrode filling solution to give final
amphotericin and DMSO concentrations of 100 µg/mL and 0.2%
(vol/vol), respectively. The tip of the pipette was dipped into
amphotericin-free solution for 2 s, pipettes were then backfilled
with ionophore, and gigaseals were formed as rapidly as possible.
Access resistance decreased to 7 to 10 M
within
20 minutes of
seal formation, and then experimental protocols were begun. In all
plots of cell volume, time 0 is defined as the time of seal formation.
Cell volume remained unchanged as amphotericin inserted into the patch
and equilibrium was established across the perforated-patch
membrane.
An Axoclamp 200A amplifier (Axon) was used to record whole-cell currents. Voltage clamp protocols, electrophysiological and video data acquisition, and off-line data analysis were controlled by custom programs written in ASYST (Keithley). Slow voltage ramps (28 mV/s) were applied to examine quasisteady-state currents that may contribute to regulation of cell volume. The voltage was stepped from 80 mV to +40 mV for 20 ms; ramped to 100 mV over 5 s; and, after 10 ms, ramped back to +40 mV over 5 s. Currents elicited by the depolarizing and hyperpolarizing legs of the ramp were virtually identical22 and were averaged to cancel the small capacitative current. Ramp currents were digitized at 1 kHz after low-pass filtering at 200 Hz. Membrane capacitance was calculated from the integral of the current transient in response to 10-mV hyperpolarizing pulses. The bath was grounded via a 3 mol/L KCl agar bridge, and the reported membrane potential (Em) values were corrected for the liquid junction potential between the bath and the pipette.
Determination of Relative Cell Volume
Methods for determining relative cell volume have been described
previously.28 29 An inverted microscope (Diaphot; Nikon,
Inc) equipped with Hoffman modulation optics (x40; 0.55 numerical
aperture) and a high-resolution TV camera (CCD72; Dage-MTI) coupled to
a video frame grabber (Targa-M8; Truevision) was used to image
myocytes. Images were captured on-line each time a ramp protocol was
performed. A combination of commercial (MOCHA; SPSS)
and custom (ASYST; Keithley) programs was used to determine
cell width, length, and the planar area of the image.
Changes in cell width and thickness on exposure to anisosmotic solutions are proportional.30 Using each cell as its own control, relative cell volume was calculated as follows: volt/volc= (areatxwidtht)/(areacxwidthc), where t and c refer to test (eg, 0.6T) and control (1T) solutions, respectively. The value of relative cell volume is independent of assumptions regarding the geometric shape of the cross section of the myocyte as long as the shape does not change. These methods provide estimates of relative cell volume that are reproducible to <1%.28 29 30
Statistics
Data are reported as mean±SEM, and n represents the
number of cells, unless otherwise noted. Mean current densities were
expressed in pA/pF to account for differences in cell membrane area.
When multiple comparisons were made, ANOVA and Bonferroni's method for
group comparisons were used. For simple comparisons, a Student's
t test was performed. All statistical analyses were
conducted with SigmaStat 2.0 (SPSS).
| Results |
|---|
|
|
|---|
|
ICl,swell in Normal Canine
Ventricular Myocytes
An outwardly rectifying Cl current that is
activated by osmotic swelling and blocked by 9AC has been
identified in cardiac myocytes and is termed
ICl,swell.1 2 3 The effect
of osmotic swelling on whole-cell currents in isolated canine
ventricular myocytes under perforated-patch conditions is
shown in Figure 1A
. A 5-minute exposure
to 0.6T hyposmotic solution containing permeant anions and cations
evoked an outwardly rectifying current at potentials positive to 65
mV and an inwardly rectifying current at more negative potentials.
Returning to isosmotic solution (1T) completely restored the initial
current-voltage (I-V) relationship.
|
Cells then were treated with 1 mmol/L 9AC, a blocker of
ICl,swell, and the effect of osmotic
swelling on membrane current was tested again (Figure 1B
). 9AC
did not affect the I-V relationship in 1T solution, but the
Cl channel blocker substantially reduced the
outwardly rectifying current evoked by osmotic swelling. 9AC-sensitive
difference currents in 1T and 0.6T solutions, calculated as the current
in 9AC-free solution minus that in the presence of 1 mmol/L 9AC,
are shown Figure 1C
. During osmotic swelling, 9AC blocks an
outwardly rectifying current that reversed near 33 mV. This value is
similar to the Cl- equilibrium potential,
ECl, of 31.6 mV calculated from
bath and pipette solutions. In contrast, 9AC-sensitive current was
negligible in 1T solution when swelling- or stretch-activated
channels (SACs) were expected to be closed. A
swelling-activated, outwardly rectifying, 9AC-sensitive current
was seen in 13 of 18 normal cells tested. However, all of the
swelling-activated current was not blocked by 9AC. A
9AC-insensitive inwardly rectifying component previously was shown to
be a Gd3+-sensitive swelling-activated
cation current.21 22
The magnitude of ICl,swell was related to
the extent of myocyte swelling. The I-V relationship and
relative cell volume were recorded simultaneously in
selected hyposmotic (0.6T to 0.9T), isosmotic (1T), and hyperosmotic
(1.5T) solutions±1 mmol/L 9AC, and 9AC-sensitive currents at each
osmolarity are plotted in Figure 2A
. 9AC
had no effect on the I-V relationship under isosmotic
conditions and after cell shrinkage in 1.5T. In contrast, a significant
9AC-sensitive current (0.25±0.02 pA/pF at 80 mV,
P<0.001) was recorded in 0.9T solution after only a
modest increase in cell volume (7.0±1.1%, P=0.002), and
further swelling increased the 9AC-sensitive current. Nevertheless, the
currents in 0.7T and 0.6T solutions were not distinguishable
(0.56±0.04 versus 0.60±0.04 pA/pF at 80 mV, P=0.5;
1.76±0.18 versus 2.06±0.21 pA/pF at +40 mV, P=0.31),
although myocyte swelling was significantly greater in 0.6T than 0.7T
solution (Figure 2B
).
|
Figure 2B
also shows that 9AC increased cell volume in
hyposmotic solutions coincident with block of the outwardly rectifying
swelling-activated current. For example, relative cell volume
increased from 1.311±0.014 in 0.6T solution to 1.381±0.013 in
0.6T+9AC (P=0.006). In contrast, 9AC did not alter cell
volume in 1T or 1.5T solutions in which 9AC-sensitive currents were not
detected. The effects of 9AC on membrane current and cell volume are
summarized in Figure 2C
, in which the 9AC-sensitive current at
80 mV and 9AC-induced cell swelling are plotted against
superfusate osmolarity. Both actions of 9AC became apparent and
saturated over the same range of osmolarities, 0.9T to 0.6T, and
neither cell volume nor membrane current was affected in 1T or 1.5T
solutions.
Persistent Activation of 9AC-Sensitive Current in CHF
Myocytes
In tachycardia-induced
cardiomyopathy, a
Gd3+-sensitive, inwardly rectifying cation SAC,
ICir,swell, is chronically
activated under isosmotic conditions and is inhibited by cell
shrinkage in hyperosmotic solution.22 Therefore, we
investigated whether the regulation of swelling-activated,
9AC-sensitive current also is remodeled in pacing-induced CHF. To test
this possibility, the 9AC-sensitive current and cell volumes of
myocytes isolated from CHF dogs were measured
simultaneously at osmolarities ranging from 0.6T to
1.5T.
Measurement of the 9AC-sensitive current in a CHF cell is illustrated
in Figure 3
. I-V relationships
were recorded in the absence (Figure 3A
) and presence
(Figure 3B
) of 1 mmol/L 9AC both in 1T solution and after
osmotic shrinkage in 1.5T solution, and the 9AC-sensitive difference
currents are plotted (Figure 3C
). A 9AC-sensitive, outwardly
rectifying current that reversed at 34 mV was observed under
isosmotic conditions (1T) in the CHF cell and was abolished after cell
shrinkage in hyperosmotic 1.5T solution. Persistent activation of the
9AC-sensitive current under isosmotic conditions in CHF myocytes
sharply contrasts with results from normal cells (compare Figures 2C
and 3C
), in which osmotic swelling was required to
activate the 9AC-sensitive current.
|
The dependence of the I-V relationship for 9AC-sensitive
current on osmotic cell swelling in CHF cells is characterized in
Figure 4
. Graded swelling of cells in
hyposmotic solutions (0.9T to 0.6T) did not significantly increase the
9AC-sensitive current at 80 mV from the current observed in 1T
solution (Figure 4A
, P=0.535). Consistent
with the observation that ICl,swell was
persistently activated, exposure to 9AC caused a cell swelling
of 7.6±0.8% under isosmotic conditions in CHF cells, and osmotic
swelling did not significantly increase the 9AC-induced cell swelling
(Figure 4B
, P=0.109). The reversal potential
(Erev) for the 9AC-sensitive current in CHF
myocytes was 33.1±0.7 mV in 1T solution, indistinguishable from that
in normal myocytes in 0.6T solution (compare Figures 2A
and 4A
). The finding that 9AC-sensitive current and 9AC-induced cell
swelling were independent of solution osmolarity is more clearly
illustrated in Figure 4C
, in which the responses to 9AC are
plotted as a function of solution osmolarity. 9AC-sensitive effects
were seen in 22 of 23 CHF cells under isosmotic conditions (Figures 4
, 5
, and 7
); the 9AC-sensitive current at 80 mV
was 0.77±0.05 pA/pF, and 9AC caused a 7.9±0.5% cell swelling.
|
|
|
The similarity between the responses of CHF cells to 9AC under
isosmotic conditions and that of normal cells after osmotic swelling
suggested that CHF myocytes behave as if they are swollen even under
isosmotic conditions, as was previously argued to explain the behavior
of cation SACs in the same CHF model.22 If this idea is
correct, osmotic cell shrinkage would be expected to block the
9AC-sensitive current and 9AC-induced cell swelling in CHF cells. To
test this possibility, the response of 9AC in CHF cells in isosmotic
solution (1T) was compared with that in hyperosmotic solution (1.1T to
1.5T). Figure 5A
shows that graded
osmotic shrinkage caused a graded reduction in the magnitude of the
9AC-sensitive current, and ICl,swell was
undetectable in 1.4T solution. Concurrently with the reduction of
ICl,swell, 9AC-induced cell swelling
decreased as bathing solution osmolarity was increased (Figure 5B
). The dependence of the responses to 9AC on solution
osmolarity are summarized in Figure 5C
.
Cell Volume Dependence of 9AC Sensitivity of Normal and CHF
Myocytes
The responses of normal and CHF myocytes are directly compared in
Figure 6
, in which the 9AC-sensitive
current at 80 mV (Figure 6A
) and the 9AC-induced cell swelling
(Figure 6B
) are plotted as functions of cell volume before
application of 1 mmol/L 9AC in 0.6T to 1.5T solution. CHF cells
remained responsive to 9AC even after shrinking to 0.872±0.011 in 1.3T
solution, whereas normal cells became sensitive to 9AC only after
swelling to 1.071±0.008 in 0.9T solution. The maximum response to 9AC
was observed at cell volumes
1.073±0.011 (
0.9T) in CHF cells and
1.254±0.012 (
0.7T) in normal cells, respectively. Thus, the set
point for 9AC sensitivity appeared to be shifted to a relative cell
volume
0.18 lower in CHF cells than in normal myocytes. The
9AC-sensitive current and volume changes in Figure 6C
are
plotted as a percentage of the maximal 9AC-induced change. The
relationship between block of current and cell swelling was linear over
the range of osmolarities explored and suggests a tight coupling of
these processes.
|
Myocytes were harvested from both the left and right ventricles of CHF
and normal dogs. Table 2
shows that the
source of the cells had no significant effect on 9AC-sensitive current
or 9AC-induced cell swelling. Consequently, data from right- and
left-ventricular myocytes have been combined.
|
Dose Dependence of Effect of 9AC on Myocyte Volume and
Current
Inhibition of ICl,swell by 9AC
and the ensuing cell swelling were dose dependent in both normal and
CHF cells. Normal cells first were swollen in NMDG-0.6T solution to
activate ICl,swell in the absence
of cation SAC current, ICir,swell, and then
were exposed for 5-minute periods to successively higher doses of 9AC
(0.01 to 1 mmol/L) in 0.6T solution. As the 9AC concentration was
increased, the magnitude of the blocked current (Figure 7A
) and cell volume (Figure 7B
)
both increased significantly in a graded fashion. The dose dependence
of the effects of 9AC are compared in Figure 7C
with the
responses at 1 mmol/L scaled to an equal height. This emphasizes
that block of current and cell swelling were proportional at different
concentrations of 9AC. Analogous experiments were conducted on CHF
myocytes in NMDG-1T solution. 9AC-sensitive currents (Figure 7D
)
and 9AC-induced cell swelling (Figure 7E
) are illustrated.
Stepwise increases in 9AC concentration elicited a proportional block
of current at 80 mV and cell swelling in CHF cells (Figure 7F
), as it did in normal cells (Figure 7C
).
Figures 7A
and 7D
also provide information on the efficacy of
9AC as a blocker of ICl,swell. The
magnitude of ICl,swell can be estimated as
the current elicited on switching from NMDG-1T to NMDG-0.6T solution
for normal cells (Figure 7A
, curve b-a) and from NMDG-1T to
NMDG-1.5T solution for CHF cells (Figure 7D
, curve a-b). The
maximum dose of 9AC used, 1 mmol/L, blocked 93±1% and 89±1% of
ICl,swell at 80 mV in normal (Figure 7A
, curve b-e) and CHF (Figure 7D
, curve a-e) cells,
respectively.
Ionic Basis of 9AC-Sensitive Current and Volume Changes
Experiments in NMDG solutions (Figure 8
) indicated that
Na+ and K+ were not
required to elicit a 9AC-sensitive current or 9AC-induced cell
swelling. If 9AC is acting as a Cl channel
blocker,1 18 replacement of Cl
with a larger, poorly permeant anion should markedly attenuate the
effects of 9AC effect on membrane current and cell volume. To test this
prediction, methanesulfonate was substituted for all
Cl in the bath, and all but 5 mmol/L
Cl in the pipette was replaced with aspartate.
Replacement of Cl essentially abolished the
effect of 9AC on membrane current (Figure 8A
and 8C
) and cell
volume (Figure 8B
and 8D
) in normal cells in 0.6T solution and
CHF cells in 1T solution.
|
| Discussion |
|---|
|
|
|---|
40% greater in CHF myocytes than in normal myocytes. The currents
recorded in both normal and CHF cells reversed at the same
potential and were blocked in a dose-dependent manner by 9AC, a blocker
of ICl,swell. Concurrent with block of
ICl,swell, 9AC caused cell volume to
increase. The 9AC-induced cell swelling was proportional to the
magnitude of ICl,swell and the
concentration of 9AC. Thus, swelling-activated anion channels
may modulate cardiac electrical activity and cell volume in CHF.
Characteristics of ICl,swell
The currents described here in both normal and CHF cells (1)
were dependent on cell volume, (2) were dependent on
Cl with Erev near
ECl, (3) were insensitive to replacement of
bath Na+ and K+ by NMDG,
(4) exhibited outward rectification under asymmetric conditions, and
(5) were attenuated by 9AC. These features match those of
ICl,swell, described by
Tseng1 in normal canine ventricular cells
and Sorota2 in normal canine atrial cells.
ICl,swell is found in normal cells from a
number of species31 including
humans.6 7 32 33 Sorota18 found that 9AC
blocked by 50%, whereas niflumic acid completely blocked
ICl,swell at all voltages. Block by
4,4'-dinitrostilbene-2,2'-disulfonic acid (DNDS) was voltage dependent,
with only partial block at negative voltages and complete block at
membrane voltages >0 mV.18 Preliminary data confirm
that niflumic acid completely blocks
ICl,swell (H.F.C. and C.M.B., unpublished
data, 1998), but the present study found that 9AC blocks
>90% of ICl,swell (see Figure 7
)
in canine myocytes at all membrane voltages. The reasons for the
discrepancy between the present results and those of
Sorota18 on the efficacy of 9AC are unclear but may
include methodological differences or subtle differences between canine
atrial and ventricular myocytes. Sorota2 was
unable to elicit ICl,swell in canine
ventricular myocytes using the nystatin-perforated-patch
method but did observe this current in canine atrial myocytes under the
same conditions.
We found that substitution of methanesulfonate in the bath for
Cl caused almost complete inhibition of
ICl,swell in both CHF and normal cells (see
Figure 8
). Others have reported that the permeability ratio
PCl/Pmethanesulfonate
is 0.25 to 0.35 in cardiac myocytes.5 7 34 The
pipette Cl concentration
([Cl]I) in these
studies was on the order of 40 mmol/L, considerably higher than
the 6 mmol/L used in the present Cl
substitution experiments. It is possible that
[Cl]i modulates the
selectivity of ICl,swell. Also, other
studies typically use a ruptured rather than a perforated-patch voltage
clamp.
A number of molecular candidates for ICl,swell have been proposed, including ClC-2,8 PICln,9 10 P-glycoprotein,11 12 phospholemman,13 and ClC-3.14 Presently, the most likely candidate for ICl,swell appears to be ClC-3, a member of the Cl channel superfamily (for review, see References 35 and 3635 36 ). This channel protein has been isolated from guinea pig ventricle,14 as well as from other tissues and species. Key characteristics of the ClC-3 channel include (1) outward rectification, (2) anion selectivity with I>Cl, and (3) activation and inactivation of current by protein kinase C (PKC) inhibition and stimulation, respectively.14 37 38 We recently demonstrated that ICl,swell in normal rabbit39 and canine40 ventricular myocytes shares these 3 properties and thus may be caused by ClC-3.
ICl,swell in CHF
This study demonstrates that a Cl current
is active under isosmotic conditions in canine CHF myocytes.
Bénitah et al41 recently reported that a
9AC-sensitive Cl current was present in rat
ventricular myocytes obtained from a pressure-overload
model (aortic constriction) of hypertrophy but not in
normal cells. The authors did not test whether the
Cl current they observed in hypertrophied rat
myocytes was sensitive to cell volume and did not identify it as
ICl,swell. It is likely, however, that the
current found by Bénitah et al41 was the same
as that identified here and shown to be volume sensitive. Moreover,
preliminary data from CHF myocytes from both the present canine
rapid pacing model (H.F.C. and C.M.B., unpublished data, 1998)
and a rabbit aortic regurgitation model39
strongly suggest that persistently activated
ICl,swell arises from ClC-3.
ICl,swell recorded in 1T in myocytes
from both CHF models exhibits I>Cl
selectivity and is inhibited by activation of PKC by
phorbol-12,13-dibutyrate. Taken together, these data suggest that
persistent activation of ICl,swell during
the myocardial remodeling associated with hypertrophy and
failure is not peculiar to a particular model of CHF or experimental
species but rather is a common feature of several models in several
species.
In both the dog and rabbit, ICl,swell current density was 40% greater in CHF than in normal cells. Presently, it is not known whether increased expression of ICl,swell channels, increased probability of channel opening, or an increased unitary conductance in CHF cells can explain these differences. Others have described an increase in ICl,swell current density in cardiac hypertrophy41 and cell proliferation.42
As previously mentioned, inactivation of PKC appears to stimulate ICl,swell in heart.38 39 CHF induced in the rabbit by left-ventricular pressure and volume overload causes a reduction in the expression of a number of PKC isoforms.43 Heart failure in the rabbit induced by pressure overload (aortic constriction) also causes a decrease in the particulate PKC fraction,44 which is in contrast to an overall increase in PKC activity and content in a similar rat model.45 46 Thus, a reduction of particulate PKC activity in CHF cells under isosmotic conditions or in normal cells under hyposmotic conditions could underlie activation of ICl,swell. Another possible mediator of ICl,swell is tyrosine kinase. Sorota47 found that genistein, an inhibitor of tyrosine kinase, prevented activation of ICl,swell by hyposmotic bath solution in canine atrial myocytes. Further, both cell swelling48 and stretch49 rapidly initiate tyrosine kinase-dependent activation of immediate-early genes such as c-fos in rat cardiac myocytes. Given that tyrosine kinases mediate angiotensin II-stimulated cell responses to hypertension, ischemic insult, and CHF,50 a tyrosine kinasedependent activation of ICl,swell in CHF is possible, although not proven at the present time.
Pathophysiology
At positive membrane potentials,
ICl,swell is outwardly directed and
presumably contributes to membrane repolarization in phases 2 and 3 of
the action potential and will thus shorten the action potential.
Vandenberg et al15 showed that acute swelling of
guinea pig ventricular myocytes causes action potential
shortening that could be attenuated by the
ICl,swell blocker
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS). The cardiac
action potential is prolonged in humans with heart failure, cardiac
hypertrophy, or ischemic
cardiomyopathy.51 52 53 Activation
of ICl,swell by CHF (as demonstrated in
this study) or by cardiac hypertrophy41
may thus serve to limit the extent of action potential prolongation in
various pathological states. Indeed, Bénitah et al41
showed that action potentials of hypertrophied rat
ventricular myocytes prolonged when treated with the
ICl,swell blocker 9AC. At negative membrane
potentials, ICl,swell is inwardly directed
and when activated should cause membrane depolarization. Cell
swelling causes membrane depolarization in both canine atrial
myocytes16 and in guinea pig ventricular
myocytes.15 This membrane depolarization was blocked by
ICl,swell blockers such as niflumic acid
and DIDS.
In summary, ICl,swell was shown to be chronically activated in canine tachycardia-induced cardiomyopathy, and it appears likely that the same current is chronically activated in other forms of CHF and cardiac hypertrophy. Although the pathophysiological role of ICl,swell presently is uncertain, it may contribute to ventricular dysrhythmias associated with hypertrophy and failure.
| Acknowledgments |
|---|
Received September 29, 1998; accepted November 5, 1998.
| References |
|---|
|
|
|---|
2.
Sorota S. Swelling-induced chloride-sensitive current
in dog atrial cells revealed by whole cell patch clamp method.
Circ Res. 1992;70:679687.
3.
Hagiwara N, Masuda H, Shoda M, Irisawa H.
Stretch-activated anion currents of rabbit cardiac myocytes.
J Physiol (Lond). 1992;456:285302.
4. Coulombe A, Coraboeuf E. Large-conductance chloride channels of new-born rat cardiac myocytes are activated by hypotonic media. Pflügers Arch. 1992;422:143150.
5.
Zhang J, Rasmusson RL, Hall SK, Lieberman M. A
chloride current associated with swelling of cultured chick heart
cells. J Physiol (Lond). 1993;472:801820.
6. Sakai R, Hagiwara N, Kasanuki H, Hosoda S. Chloride conductance in human atrial cells. J Mol Cell Cardiol. 1995;27:24032408.[Medline] [Order article via Infotrieve]
7.
Li GR, Feng J, Wang Z, Nattel S. Transmembrane
chloride currents in human atrial myocytes. Am J
Physiol. 1996;270:C500C507.
8. Grunder S, Thiemann A, Pusch M, Jentsch TJ. Regions involved in the opening of ClC-2 chloride channel by voltage and volume. Nature. 1992;360:759762.[Medline] [Order article via Infotrieve]
9. Paulmichl M, Li Y, Wickman K, Ackerman M, Peralta E, Clapham D. New mammalian chloride channel identified by expression cloning. Nature. 1992;356:238241.[Medline] [Order article via Infotrieve]
10. Krapivinsky GB, Ackerman MJ, Gordon EA, Krapivinsky LD, Clapham DE. Molecular characterization of a swelling-induced chloride conductance regulatory protein, PICln. Cell. 1994;76:439448.[Medline] [Order article via Infotrieve]
11. Gill DR, Hyde SC, Kiggins DF, Valverde MA, Minteng GM, Sepulveda FV. Separation of drug transport and chloride channel functions of human multidrug resistance P-glycoprotein. Cell. 1992;71:2332.[Medline] [Order article via Infotrieve]
12. Valverde MA, Diaz M, Sepulveda M, Gill DG, Hyde SC, Higgins CF. Volume regulated chloride channels are associated with the human multidrug-resistance P-glycoprotein. Nature. 1992;355:830833.[Medline] [Order article via Infotrieve]
13.
Moorman JR, Palmer CJ, John JD, Durieux ME, Jones LR.
Phospholemman expression induces a
hyperpolarization-activated chloride
current in Xenopus oocytes. J Biol Chem. 1992;267:1455114554.
14. Duan DD, Cowley S, Hume JR, Horowitz B. Molecular identification of a volume-regulated chloride channel. Nature. 1997;390:417421.[Medline] [Order article via Infotrieve]
15.
Vandenberg JI, Bett GC, Powell T. Contribution of a
swelling-activated chloride current to changes in the cardiac
action potential. Am J Physiol. 1997;273:C541C547.
16.
Du XY, Sorota S. Cardiac swelling-induced chloride
current depolarizes canine atrial myocytes. Am J
Physiol. 1997;272:H1904H1916.
17. Suleymanian MA, Clemo HF, Cohen NM, Baumgarten CM. Stretch-activated channel blockers modulate cell volume in cardiac ventricular myocytes. J Mol Cell Cardiol. 1995;27:721728.[Medline] [Order article via Infotrieve]
18. Sorota S. Pharmacologic properties of the swelling-induced chloride current of dog atrial myocytes. J Cardiovasc Electrophysiol. 1994;5:10061016.[Medline] [Order article via Infotrieve]
19. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 1997;59:551571.[Medline] [Order article via Infotrieve]
20. Packer M. New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms. J Intern Med. 1996;239:327333.[Medline] [Order article via Infotrieve]
21.
Clemo HF, Baumgarten CM. Swelling-activated
Gd3+-sensitive current and cell volume regulation
in rabbit ventricular myocytes. J Gen
Physiol. 1997;110:297312.
22.
Clemo HF, Stambler BS, Baumgarten CM. Persistent
activation of a swelling-activated cation current in
ventricular myocytes from dogs with
tachycardia-induced congestive heart failure. Circ
Res. 1998;83:147157.
23. Iannini JP, Spinale FG. The identification of contributory mechanism for the development and progression of congestive heart failure in animal models. J Heart Lung Transplant. 1996;15:11381150.[Medline] [Order article via Infotrieve]
24. Morgan JP. Cellular physiology of myocyte contraction. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:111.
25. Weber KT. Cardiac interstitium. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:1331.
26. Swynghedauw B. Biologic determinants of myocardial function. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:3344.
27. Francis GS. Vasoactive hormone systems. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997:215234.
28.
Clemo HF, Baumgarten CM. Atrial natriuretic
factor decreases cell volume of rabbit atrial and
ventricular myocytes. Am J Physiol. 1991;260:C681C690.
29.
Clemo, HF, Feher JJ, Baumgarten CM. Modulation of
rabbit ventricular cell volume and
Na+/K+/2Cl
cotransport by cGMP and atrial natriuretic factor.
J Gen Physiol. 1992;100:89114.
30.
Drewnowska K, Baumgarten CM. Regulation of cellular
volume in rabbit ventricular myocytes: bumetanide,
chlorothiazide, and ouabain. Am J
Physiol. 1991;260:C122C131.
31. Nilius B, Eggermont J, Voets T, Buyse G, Manolopoulos V, Droogmans G. Properties of volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol. 1997;68:69119.[Medline] [Order article via Infotrieve]
32.
Oz MC, Sorota S. Forskolin stimulates swelling-induced
chloride current, not cardiac cystic fibrosis transmembrane-conductance
regulator current, in human cardiac myocytes. Circ Res. 1995;76:10631070.
33. Sato R, Koumi S-I. Characterization of the stretch-activated chloride channel in isolated human atrial myocytes. J Membr Biol. 1998;163:6776.[Medline] [Order article via Infotrieve]
34. Leem CH, Ho W-K, Earm YE. The effect of taurine on the activation osmolality of the osmosensitive current in single ventricular myocytes of rabbits. Exp Physiol. 1996;81:189202.[Abstract]
35. Jentsch TJ, Günther W. Chloride channels: an emerging molecular picture. Bioessays. 1997;19:119126.
36.
Clapham DE. The list of potential volume-sensitive
chloride currents continues to swell (and shrink). J Gen
Physiol. 1998;111:623624.
37. Kawasaki M, Uchida S, Monkasva T, Miyawaki A, Mikoshiba K, Marumo F, Sasaki S. Cloning and expression of a protein kinase C-regulated chloride channel abundantly expressed in rat brain neuronal cells. Neuron. 1994;12:597604.[Medline] [Order article via Infotrieve]
38.
Duan D, Fermini B, Nattel S.
-Adrenergic
control of volume-regulated Cl currents in
rabbit atrial myocytes. Circ Res. 1995;77:373393.
39. Clemo HF, Baumgarten CM. Protein kinase C activation blocks ICl,swell and causes myocyte swelling in a rabbit congestive heart failure model. Circulation. 1998;98(suppl I):I-695. Abstract.
40. Clemo HF, Danetz JS, Baumgarten CM. Does ClC-3 modulate cardiac cell volume? Biophys J. 1999;76:A203. Abstract.
41.
Bénitah, J-P, Gómez AM, Delgado C, Lorente
P, Lederer WJ. A chloride current component induced by
hypertrophy in rat ventricular myocytes.
Am J Physiol. 1997;272:H2500H2506.
42.
Voets T, Wei L, De Smet P, Van Driessche W, Eggermont
J, Droogmans G, Nilius B. Downregulation of volume-activated
Cl currents during muscle differentiation.
Am J Physiol. 1997;272:C667C674.
43.
Rouet-Benzineb P, Mohammadi K, Pérennec J, Poyard
M, El Houda Bouanani N, Crozatier B. Protein kinase C isoform
expression in normal and failing rabbit hearts. Circ Res. 1996;79:153161.
44. Mohammadi K, Rouet-Benzineb P, Laplace M, Crozatier B. Protein kinase C activity and expression in rabbit left ventricular hypertrophy. J Mol Cell Cardiol. 1997;29:16871694.[Medline] [Order article via Infotrieve]
45. Kwiatkowska-Patzer B, Domanska-Janik K. Increased 19 kDa protein phosphorylation and protein kinase C in pressure-overload cardiac hypertrophy. Basic Res Cardiol. 1991;86:402409.[Medline] [Order article via Infotrieve]
46.
Gu X, Bishop SP. Increased protein kinase C and isozyme
redistribution in pressure-overload cardiac hypertrophy in
the rat. Circ Res. 1994;75:926931.
47. Sorota S. Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current. Pflügers Arch. 1995;431:178185.
48. Sadoshima J, Qiu Z, Morgan JP, Izumo S. Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J. 1996;15:55355546.[Medline] [Order article via Infotrieve]
49. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12:16811692.[Medline] [Order article via Infotrieve]
50.
Berk BC, Corson MA. Angiotensin II signal
transduction in vascular smooth muscle. Circ Res. 1997;80:607616.
51.
Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman
MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in
myocardium from patients with end-stage heart failure.
Circ Res. 1987;61:7076.
52.
Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular
calcium handling in isolated ventricular myocytes from
patients with terminal heart failure. Circulation. 1992;85:10461055.
53.
Koumi S, Backer CL, Arentzen CE. Characterization of
inwardly rectifying K+ channel in human cardiac
myocytes: alterations in channel behavior in myocytes isolated from
patients with idiopathic dilated cardiomyopathy.
Circulation. 1995;92:164174.
54. Gerdes AM, Kellerman SE, Malec KB, Schocken D. Transverse shape characteristics of cardiac myocytes from rats and humans. Cardioscience. 1994;5:3136.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
D. Duan Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart J. Physiol., May 1, 2009; 587(10): 2163 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C De Mello Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications for myocardial ischaemia Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 112 - 118. [Abstract] [PDF] |
||||
![]() |
S. J. Kim and Y. E. Earm Journeying down the long and winding road: the whole picture of volume-activated Cl- channel activation in cardiac myocytes Cardiovasc Res, January 1, 2008; 77(1): 6 - 7. [Full Text] [PDF] |
||||
![]() |
Z. Ren, F. J. Raucci Jr., D. M. Browe, and C. M. Baumgarten Regulation of swelling-activated Cl- current by angiotensin II signalling and NADPH oxidase in rabbit ventricle Cardiovasc Res, January 1, 2008; 77(1): 73 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Verkerk, A. C.G. van Ginneken, G. Berecki, H. M. den Ruijter, C. A. Schumacher, M. W. Veldkamp, A. Baartscheer, S. Casini, T. Opthof, R. Hovenier, et al. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials Cardiovasc Res, June 1, 2006; 70(3): 509 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Browe and C. M. Baumgarten EGFR Kinase Regulates Volume-sensitive Chloride Current Elicited by Integrin Stretch via PI-3K and NADPH Oxidase in Ventricular Myocytes J. Gen. Physiol., February 27, 2006; 127(3): 237 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ren and C. M. Baumgarten Antagonistic regulation of swelling-activated Cl- current in rabbit ventricle by Src and EGFR protein tyrosine kinases Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2628 - H2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Browe and C. M. Baumgarten Angiotensin II (AT1) Receptors and NADPH Oxidase Regulate Cl- Current Elicited by {beta}1 Integrin Stretch in Rabbit Ventricular Myocytes J. Gen. Physiol., August 30, 2004; 124(3): 273 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-E. Chiang, H.-N. Luk, and T.-M. Wang Swelling-activated chloride current is activated in guinea pig cardiomyocytes from endotoxic shock Cardiovasc Res, April 1, 2004; 62(1): 96 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Browe and C. M. Baumgarten Stretch of {beta}1 Integrin Activates an Outwardly Rectifying Chloride Current via FAK and Src in Rabbit Ventricular Myocytes J. Gen. Physiol., November 24, 2003; 122(6): 689 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Akar, T. H. Everett, R. Ho, J. Craft, D. E. Haines, A. P. Somlyo, and A. V. Somlyo Intracellular Chloride Accumulation and Subcellular Elemental Distribution During Atrial Fibrillation Circulation, April 8, 2003; 107(13): 1810 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicolosi, G. West, J. G. Markley, B. Logan, and G. N. Olinger Gadolinium attenuates regional stunning in the canine heart in vivo J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M.G.J van Borren, A. O Verkerk, S. K Vanharanta, A. Baartscheer, R. Coronel, and J. H Ravesloot Reduced swelling-activated Cl- current densities in hypertrophied ventricular myocytes of rabbits with heart failure Cardiovasc Res, March 1, 2002; 53(4): 869 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Verkerk, M. W. Veldkamp, A. Baartscheer, C. A. Schumacher, C. Klopping, A. C.G. van Ginneken, and J. H. Ravesloot Ionic Mechanism of Delayed Afterdepolarizations in Ventricular Cells Isolated From Human End-Stage Failing Hearts Circulation, November 27, 2001; 104(22): 2728 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Harding, V. Piacentino III, J. P. Gaughan, S. R. Houser, and K. B. Margulies Electrophysiological Alterations After Mechanical Circulatory Support in Patients With Advanced Cardiac Failure Circulation, September 11, 2001; 104(11): 1241 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaab and M. Nabauer Diversity of ion channel expression in health and disease Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K31 - K40. [Abstract] [PDF] |
||||
![]() |
A. Y. Estevez, T. Bond, and K. Strange Regulation of ICl,swell in neuroblastoma cells by G protein signaling pathways Am J Physiol Cell Physiol, July 1, 2001; 281(1): C89 - C98. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicolosi, C. S. Kwok, S. J. Contney, G. N. Olinger, and Z. J. Bosnjak Gadolinium prevents stretch-mediated contractile dysfunction in isolated papillary muscles Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1122 - H1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Q. He, M. W Conklin, J. D Foell, M. R Wolff, R. A Haworth, R. Coronado, and T. J Kamp Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failure Cardiovasc Res, February 1, 2001; 49(2): 298 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Danetz, R. D. Davies, H. F. Clemo, and C. M. Baumgarten RABBIT VENTRICULAR MYOCYTE VOLUME CHANGES AS A DIRECT RESULT OF CRYSTALLOID CARDIOPLEGIA IN CONGESTIVE HEART FAILURE INDUCED BY AORTIC REGURGITATION J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 826 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagasaki, L. Ye, D. Duan, B. Horowitz, and J. R Hume Intracellular cyclic AMP inhibits native and recombinant volume-regulated chloride channels from mammalian heart J. Physiol., March 15, 2000; 523(3): 705 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz Anion Transport in Heart Physiol Rev, January 1, 2000; 80(1): 31 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Danetz, H. F. Clemo, R. D. Davies, R. P. Embrey, R. J. Damiano Jr, and C. M. Baumgarten AGE-RELATED EFFECTS OF ST THOMAS’ HOSPITAL CARDIOPLEGIC SOLUTION ON ISOLATED CARDIOMYOCYTE CELL VOLUME J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-R. Li, M. Zhang, L. S. Satin, and C. M. Baumgarten Biphasic effects of cell volume on excitation-contraction coupling in rabbit ventricular myocytes Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1270 - H1277. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |